Drug regulatory Authority of Pakistan (DRAP) has issued a
public advisory regarding the use of Celia and Gromore ( Product of M/s
Lactalis International, France) on the event of global recall of few implicated
batches by the principal manufacturer and importers as informed by the World
Health Organization (WHO). These particular batches of Celia and Gromore being
voluntary recalled were recommended for use in lactose intolerants
infants. Pursuant to the global recall, DRAP has taken prompt action and
activated the Federal Inspectorate and Quality Assurance team for the removal
of implicated batches from the market. DRAP has collected the records of import
transaction of these batches from France. The recall process has been initiated
in collaboration with the provincial governments of Punjab, Sindh, KPK,
Baluchistan, Giglit, AJK and ICT administration, who were advised to monitor
the recall process through their surveillance force.
